Table 1 Baseline characteristics for the two groups

Recipient age (years) (median [IQR])

50 [37–57]

50 [31–57]

Donor age (years) (mean ± SD)

31 ± 18

27 ± 17

Recipient gender (male) (%)

32 (71)

39 (68)

Donor gender (female) (%)

40 (100)

49 (100)

Etiology (ischemic) (%)

17 (38)

25 (44)

Recipient BMI (kg/m²) (median [IQR])

23.7 [21.6–26.8]

23.9 [20.8–27]

Donor BMI (kg/m²) (mean ± SD)

24.6 ± 3.7

24.7 ± 2.7

Hypertension (%)

7 (16)

16 (28)

Dyslipidemia (%)

11 (24)

18 (32)

Past smoker (%)

9 (20)

15 (26)

Assist device (%)

8 (18)

7 (13)

Status 1 (%)

30 (67)

38 (67)

PRA > 30% (%)

0 (0)

1 (2)

Recipient blood type (%)

 A

17 (42)

19 (36)

 AB

4 (10)

3 (6)

 B

5 (13)

14 (27)

 O

14 (35)

16 (31)

Recipient creatinine (median [IQR])

1.11 [1–1.3]

1 [0.9–1.2]

Recipient bilirubin (median [IQR])

1 [0.7–1.2]

1 [0.63–1.35]

Tacrolimus^a (%)

19 (42)

30 (53)

Average tacrolimus^a (median [IQR])

13 [11.4–13.8]

12.5 [10.4–13.7]

Cyclosporine^a (%)

14 (31)

18 (32)

Average cyclosporine^a (mean ± SD)

296 ± 56

277 ± 37

Ischemic time (min) (mean ± SD)

169 ± 46

153 ± 40

PAM (mmHg) (mean ± SD)

35 ± 12

33 ± 13

CO (mean ± SD)

3.7 ± 1.2

3.5 ± 1.2

PVR (median [IQR])

2.2 [1.3–3]

2.3 [1.7–3.2]

CMV mismatch (%)

14 (39)

11 (33)

Statins post-HT (%)

41 (91)

53 (93)

Hypertension post-HT (%)

29 (64)

33 (58)

Average Mg in first year (mean ± SD)

2 ± 0.3

1.6 ± 0.1

Average Mg in first month (median [IQR])

2 [1.9–2.2]

1.7 [1.6–1.8]

Mg < 1.8 mg/dL in the first month (%)

3 (7)

38 (83)